GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Return-on-Tangible-Asset

APM (Aptorum Group) Return-on-Tangible-Asset : -19.20% (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Aptorum Group's annualized Net Income for the quarter that ended in Dec. 2024 was $-3.25 Mil. Aptorum Group's average total tangible assets for the quarter that ended in Dec. 2024 was $16.92 Mil. Therefore, Aptorum Group's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 was -19.20%.

The historical rank and industry rank for Aptorum Group's Return-on-Tangible-Asset or its related term are showing as below:

APM' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -77.92   Med: -40.22   Max: 21.45
Current: -23.57

During the past 8 years, Aptorum Group's highest Return-on-Tangible-Asset was 21.45%. The lowest was -77.92%. And the median was -40.22%.

APM's Return-on-Tangible-Asset is ranked better than
62.02% of 1498 companies
in the Biotechnology industry
Industry Median: -37.8 vs APM: -23.57

Aptorum Group Return-on-Tangible-Asset Historical Data

The historical data trend for Aptorum Group's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Return-on-Tangible-Asset Chart

Aptorum Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Asset
Get a 7-Day Free Trial 21.45 -77.92 -47.64 -13.91 -23.31

Aptorum Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -73.10 -63.88 30.65 -27.69 -19.20

Competitive Comparison of Aptorum Group's Return-on-Tangible-Asset

For the Biotechnology subindustry, Aptorum Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptorum Group's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Aptorum Group's Return-on-Tangible-Asset falls into.


;
;

Aptorum Group Return-on-Tangible-Asset Calculation

Aptorum Group's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-4.268/( (20.493+16.13)/ 2 )
=-4.268/18.3115
=-23.31 %

Aptorum Group's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=-3.248/( (17.705+16.13)/ 2 )
=-3.248/16.9175
=-19.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2024) net income data.


Aptorum Group  (NAS:APM) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Aptorum Group Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptorum Group Business Description

Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group Headlines

From GuruFocus

Aptorum Group Limited Announces Voluntary Delisting from Euronext Paris

By Business Wire Business Wire 06-09-2023